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ABSTRACT
The basic helix–loop–helix (bHLH).PAS dimeric tran-
scription factors have crucial roles in development,
stress response, oxygen homeostasis and neuro-
genesis. Their target gene specificity depends in
part on partner protein choices, where dimerization
with common partner Aryl hydrocarbon receptor
nuclear translocator (Arnt) is an essential step
towards forming active, DNA binding complexes.
Using a new bacterial two-hybrid system that
selects for loss of protein interactions, we have
identified 22 amino acids in the N-terminal PAS
domain of Arnt that are involved in hetero-
dimerization with aryl hydrocarbon receptor (AhR).
Of these, Arnt E163 and Arnt S190 were selective for
the AhR/Arnt interaction, since mutations at
these positions had little effect on Arnt dimerization
with other bHLH.PAS partners, while substitution of
Arnt D217 affected the interaction with both AhR
and hypoxia inducible factor-1a but not with single
minded 1 and 2 or neuronal PAS4. Arnt uses the
same face of the N-terminal PAS domain for
homo- and heterodimerization and mutational
analysis of AhR demonstrated that the equivalent
region is used by AhR when dimerizing with Arnt.
These interfaces differ from the PAS b-scaffold
surfaces used for dimerization between the
C-terminal PAS domains of hypoxia inducible
factor-2a and Arnt, commonly used for PAS
domain interactions.
INTRODUCTION
The basic helix–loop–helix (bHLH)/Per-Arnt-Sim
homology (PAS) transcription factor (TF) family
consists of at least 19 structurally related DNA binding
proteins in mammals (1). bHLH.PAS TFs are dimeric,
with networks centred around two hub proteins: aryl
hydrocarbon receptor nuclear translocator (Arnt) and
brain and muscle Arnt-like (BMAL). The BMAL cluster
is a relatively small network that regulates circadian
rhythm and includes BMAL 1 an 2, Clock 1 and 2 and
PERIOD (PER) proteins (Supplementary Figure S1). The
more extensive Arnt cluster functions in sensing environ-
mental cues such as xenobiotics [aryl hydrocarbon
receptor (AhR)] and low oxygen tension [hypoxia indu-
cible factor-as (HIF-as)], as well as participating in a
broad range of biological processes, including liver and
vascular development (AhR and HIF-a, respectively)
neurogenesis [single minded proteins (Sim1&2)], synaptic
plasticity [neuronal PAS domain protein 4 (NPAS4)] and
the progression of many cancers (1–4). Arnt, or the closely
related homologue Arnt2, are the obligate partners for
all members in the Arnt cluster, where dimerization is
required to form active, DNA binding complexes to
initiate transcription (4). The dimers recognize asymmetric
E-box-like response elements in the regulatory regions of
target genes and DNA binding speciﬁcity is directed by
Arnt’s protein partner. Arnt can also homodimerize and
bind the canonical CACGTG E-box sequence in vitro and
in vivo (5–7), and although the physiological signiﬁcance is
still unclear, the Arnt homodimer appears to be involved
in regulation of CYP2a5 in liver (5).
All bHLH.PAS proteins share similar domain architec-
ture, with a highly conserved N-terminal bHLH motif,
adjacent PAS domains, and loosely conserved
C-terminal transactivation or transrepression regions (4).
The bHLH domain is a well characterized DNA binding
and dimerization domain. Strong dimer formation often
requires collaboration between bHLH and other regions
such as PAS or leucine zipper domains. The PAS domain
is a widespread protein interaction and signal transduction
motif (8). Most bHLH.PAS TFs have two tandem PAS
domains, designated PAS A (N-terminal) and PAS B (4)
and both PAS domains contribute to dimer formation
and biological activity of transcription complexes (9–11).
The N-terminal PAS.A domains have signiﬁcant roles in
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bility (11,13) and strengthening the DNA binding (13),
and there are several instances where the PAS.A domain
alone is sufﬁcient for functional dimerization. Deletion of
PAS.B, the ligand binding domain, in AhR produces a
constitutively active receptor more potent than the intact
protein (14). The AhR Repressor, which lacks PAS.B,
competes efﬁciently with AhR for Arnt binding, to nega-
tively regulate AhR activity (15). Similarly, Inhibitory
PAS protein (IPAS), a splicing variant of HIF-3a having
only a partial PAS.B domain, negatively modulates
HIF-as activity by dimerizing with HIF-a to prevent for-
mation of active HIF-a/Arnt (16).
As PAS.A is important for directing homo- and
heterodimerization within the Arnt cluster, we sought to
identify dimerization interfaces in Arnt PAS.A, and to
determine whether a common interface is used for all
Arnt hub PAS.A interactions, or if the partner proteins
use different dimerization interfaces. Both mechanisms
are plausible, as several distinct interaction surfaces have
been identiﬁed for PAS domains, involving the N-terminal
a-helical cap, the central b-sheets or the a-helix connect-
ing the N- and C-terminal b-sheets (9,17–21). For other
dimeric TFs, such as the related bHLH Leucine
Zipper proteins and the nuclear hormone receptors, the
same interface is involved in both homo- and
hetero-dimerization, with key residues in the interface
deﬁning dimer speciﬁcity (22,23). Alternatively, prote-
asome inhibitor PI31 uses different interfaces of a sin-
gle domain for homo- and heterodimerization.
Homodimerization is mediated by a-helical interactions
between the N-terminal domain while the b-sheet on the
opposite face of this domain is involved in PI31/SCF
FBxo7
E3 ubiquitin ligase heterodimerization (24).
Structural analysis coupled with site-directed mutagen-
esis is the typical approach to investigate such questions
mechanistically. The most homologous solved structure
for Arnt PAS.A is PER, the negative regulator of circa-
dian rhythm that competes with Clock for BMAL
binding. PER has both PAS.A and PAS.B domains and
can form a homodimer, but lacks the bHLH domain and
does not bind DNA. It is likely that the PER homodimer
structure is not representative of bHLH.PAS TF inter-
actions, since the homodimer is antiparallel, where
PAS.A of one monomer interacts with PAS.B of the
second monomer (25), rather than PAS.A with PAS.A
and PAS.B with PAS.B as in bHLH.PAS TFs. The struc-
ture of the isolated PAS.B domains of the HIF2a/Arnt
dimer has also been solved and shows antiparallel dimer-
ization through the b-sheet surface (9,26). Together, these
structures reveal that PAS.A domains differ quite
markedly from PAS.B, in having up to three insertion
loops between b-stands in the domain fold (25).
In the absence of experimentally determined structures,
we have developed a novel reverse bacterial two hybrid
system (RevB2H) to investigate Arnt dimerization and
deﬁne the dimerization interface in the poorly
characterized PAS.A region. This genetic approach
provided an unbiased and versatile method which
identiﬁed 22 amino acid residues in Arnt PAS.A and
10 residues in AhR PAS.A critical for AhR/Arnt
dimerization. Residues E163 and S190 of Arnt are select-
ive for the AhR/Arnt interaction, as mutations at these
positions have little or no effect on other Arnt partner
proteins, while substitution at Arnt D217 affected the
interaction with both AhR and HIF-1a but not with
Sim1, Sim2s or NPAS4.
MATERIALS AND METHODS
RevB2H screening
System validations were performed by PCR-based
genotyping and computer-aided colony size comparisons.
For PCR genotyping, a mixture of two oligonucleotide
pairs (pTRGsense and pTRGantisense, pBTsense and
pBTantisense; Supplementary Data) priming from
ﬂanking sequences were used, giving a different size
product for each encoded protein. Colony size was
determined after 40h incubation at 34 C, when plates
were scanned and the frequency distribution of colonies
with diameter >0.2mm was scored in the images, using
ImageJ 1.42q software (http://rsbweb.nih.gov/ij/features
.html).
Plasmid construction and error-prone PCR generation
of mutagenic libraries are described in Supplementary
Data. For the Arnt PAS.A mutagenesis screen,
pBT_Arnt362_Host_LacZa mutagenic libraries were
electroporated into Escherichia coli KS1033 (27) carrying
pZS4lacOR2-62_186cI_CTD selection and
pZE1_RNAP_AhR278 expression plasmids, then
incubated on 100mg/ml Ampicillin, 30mg/ml
Chloramphenicol, 50mg/ml Spectomycin, 1mM IPTG
and 50mg/ml X-gal agar at  34 C for 40h. Recovered
plasmid DNA was digested with EcoRI to linearize
pZS4lacOR2-62_186cI CTD and pZE1_RNAP_AhR278.
Remaining intact pBT_Arnt362_Host_lacZa carrying
putative Arnt loss-of-interaction mutations was trans-
formed into either E. coli KS1 (28) harbouring
pZE1_RNAP_AhR278 expression plasmid for b-gal val-
idation or XL1-Blue for plasmid propagation and
sequencing. AhR PAS.A was screened by electroporating
pZE1_RNAP_AhR278_lacZa mutagenic libraries into
KS1033 carrying pZS4lacOR2-62_186cI_CTD and
pBT_Arnt362_Host and grown as above. Recovered
plasmid DNA was digested with XhoI to linearize
pZS4lacOR2-62_186cI_CTD and pBT_Arnt362_Host.
Intact pZE1_RNAP_AhR278_lacZa carrying putative
AhR loss-of-interaction mutations was transformed
into KS1 carrying pBT_Arnt362_Host expression
plasmid for b-gal validation. Liquid b-gal assays were per-
formed in E. coli KS1 in 96-well plates using 150mM
IPTG as described previously (29). The wt
 CI_Arnt362_Host/RNAPa_AhR278 and  CI_Arnt362/
RNAPa_AhR278_Host interactions gave 112.8±9.0
and 107.3±4.8 units of b-gal activity (mean±SEM,
n=9), respectively.
Protein puriﬁcation and circular dichroism
Expression of 6-histidine tagged proteins was carried out
as described (13). Bacterial cells, 60 OD600nm units, were
resuspended in 1ml 100mM HEPES (pH 7.5), 25U of
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Ni-afﬁnity chromatography using Maxwell 16 automatic
puriﬁcation Instrument (Promega). CD spectra were
recorded in 10mM sodium phosphate, pH 8.0, at 20 C
on a Jasco J-815 spectrometer, from 260 to 185nm in
0.2nm steps, with 1s response time and 1nm bandwidth,
recording seven accumulations per spectrum with buffer
correction. Data were normalized for differences in
protein concentration using ellipticity at 207nm to allow
comparison with wt (30); concentrations (mg/ml) were wt:
0.3, E163K: 0.3, V179A: 0.07, D217G: 0.06, M267K: 0.05.
Secondary-structure prediction and homology modelling
The positions of secondary-structure elements were
derived from structure-based alignments (25) and
secondary-structure predictions for the Arnt sequence
using Psipred (http://bioinf.cs.ucl.ac.uk/psipred/) and
PROF prediction (http://www.aber.ac.uk/ phiwww/
prof/). Homology models of Arnt and AhR PAS.A
domain were generated using SwissModel (http://
swissmodel.expasy.org/workspace/) with dPER 1WA9
(25) as template. Images were produced using UCSF
Chimera (http://www.cgl.ucsf.edu/chimera/) from the
Resource for Biocomputing, Visualization and
Informatics at the University of California, San
Francisco (NIH P41 RR-01081).
Immunoblotting and antibodies
Cell lysates were prepared in 20mM HEPES, pH 8.0,
420mM NaCl, 0.5% Igepal, 25% glycerol, 0.2mM
EDTA, 1.5mM MgCl2, 1mM DTT and protease inhibi-
tors and 20mg, was separated on 10% acrylamide SDS–
PAGE before transfer to nitrocellulose. Reporter gene
assay extracts from transfection wells were normalized
against renilla luciferase levels. Proteins were detected
using monoclonal antibodies anti-Myc (4A6, Upstate),
anti-a-tubulin (MCA78G, Serotec), anti-AhR (RPT1,
Abcom), or anti-Arnt (MA1-515, Afﬁnity BioReagents),
horseradish peroxidase-conjugated secondary antibody
and visualized by chemiluminescence. Fluorescence-
based western blotting of bacterial extracts was performed
as described (31) using afﬁnity puriﬁed anti- CI and
Cy5-labelled secondary antibody.
Ni-afﬁnity pull-down
Cytosolic proteins were prepared from cultured mouse
Hepa C4 cells by lysis in six volumes of hypotonic
buffer [1.5mM MgCl2, 10mM KCl, 10% glycerol and
protease inhibitor cocktail (Sigma) in 10mM Tris–HCl,
pH 8.0] with three freeze-thaw cycles, and centrifugation
at 14 000g, 30min, 4 C. Protein, 80mg, was treated in vitro
with vehicle (0.1% DMSO), 50nM TCDD or 50mM
YH439, incubated with Ni-NTA resin (Qiagen), washed
three times with 250mM NaCl, 20mM Imidiazole, 0.1%
Igepal and protease inhibitor cocktail (Sigma) in 20mM
HEPES, pH 8.0. Bound protein was recovered by boiling
in SDS loading buffer, before western blotting.
Transient transfections and luciferase assays
HEK293T were maintained, and dual luciferase assays
performed, as described previously (32). Cells were tran-
siently cotransfected with 200ng ﬁreﬂy luciferase reporter
plasmid [pML-6c-wt, pML-6c-X or pML-6c-AM (33)]
50ng each of puro6_HisMyc_Arnt (wt or mutant) and
puro6-based partner protein expression vectors, and
10ng of phRL-CMV Renilla luciferase reporter plasmid
(Promega) for 24h. For the XRE reporter, cells were
treated after 8h with vehicle (0.1% DMSO) or 10mM
YH439 for 16h. Relative luciferase activity was
normalized to levels with empty vector to give fold acti-
vation over basal levels from endogenous protein. For
Arnt homodimer, cells were transiently cotransfected
with 200ng 4(CACGTG)TKMPluc (6) or TKMPluc,
50ng of puro6_HisMyc_Arnt (wt or mutants) and 0.5ng
of phRL-CMV and incubated for 48h.
Lentiviral production and infection
Mouse hepatatoma C4 cell lines (34) were cultured in
a-MEM containing 10% fetal calf serum, Penicillin/
Streptomycin (1% v/v) at 37 C, 5% CO2. The production
of lentiviral particles and integration of HisMyc_Arnt wt
or mutant expression vectors to generate mouse hepato-
cyte stable expression lines has been described (32).
RNA extraction, cDNA synthesis and quantitative real
time PCR
Cultured Hepa C4 cell lines expressing wt, E163K, S190P
or D217G HisMyc_Arnt from integrated lentiviral vectors
were seeded at 1.2 10
6 cells/dish in 10cm dishes and after
48h, treated with vehicle (0.1% DMSO), 10mM YH439 or
100mM 2,20-dipyridyl (DP) for 16h. RNA was puriﬁed
and reverse transcribed and mCYP1A1 and mVEGF ex-
pression levels measured by quantitative real time PCR
(qRT–PCR) as described previously (32), with all reac-
tions performed in triplicate. The expression level of
mouse housekeeping gene hypoxanthine guanine
phosphoribosyl transferase (mHPRT), which did not
vary with treatments, was used as internal control. The
ampliﬁcation efﬁciencies for mCYP1A1, mVEGF and
mHPRT were 91.1, 93.0 and 88.5%, with amplicons of
165, 101 and 85bp, respectively.
RESULTS
Reverse bacterial two hybrid system
Our RevB2H was derived from the conventional bacterial
two hybrid method (28) by replacing the HIS3-aadA
reporter gene cassette with the 186cI CTD gene
(Figure 1). This gene encodes a form of the bacteriophage
186 cI repressor protein that lacks the N-terminal DNA
binding motif and thus acts as a dominant negative
towards full-length 186 cI. Interaction between the DNA
bound  CI-bait and the RNAPa-prey fusion proteins ac-
tivates production of the 186cI CTD protein, which in an
appropriate host strain, KS1033, results in cell death.
Escherichia coli strain KS1033 is a derivative of
XL1-Blue having stable integration of a 186(cI
ts int
 )
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186cI protein (186cI
ts). At permissive temperatures
( 34 C), expression of prophage-encoded 186cI
ts
suppresses the lytic cycle of the 186 prophage, permitting
cell growth. When interaction between the  CI-bait and
RNAPa-prey fusion proteins increases the expression of
186cI CTD, 186cI
ts is sequestered away from DNA, re-
sulting in prophage mediated cell death or signiﬁcantly
inhibited cell growth. A mutation within the proteins
fused to  CI or RNAPa that disrupts their interaction
results in reduced expression of 186cI CTD and the host
encoded 186cI
ts is then sufﬁcient for cell survival
(Figure 1a).
Initial bait and prey fusions proteins were made
where  CI was fused to human Arnt bHLH.PAS.A
residues 1–362 ( CI_Arnt362) and RNAPa was fused
to mouse AhR bHLH.PAS.A residues 1–278 (RNAPa_
AhR278), under the control of isopropyl b-D-
1-thiogalactopyranoside (IPTG) inducible lacUV5 pro-
moters. We tested the strength of interaction of these
fusion proteins by measuring b-galactosidase (b-gal)
activity in a standard forward two-hybrid system using
E. coli strain KS1, which carries the lacOR2-62_lacZ
reporter cassette on its F’ plasmid (28). The system gave
lower b-gal activity than known strong interactors
 CI_LGF2 and RNAPa_gal11p (35). Removal of the
Figure 1. Characterizing the reverse bacterial two hybrid system (RevB2H). (a) Mechanism: interaction between bait fused to bacteriophage  -CI
repressor ( CI-bait) and prey fused to RNA polymerase a-subunit (RNAPa-prey) (28) drives expression of the C-terminal domain of bacteriophage
186cI repressor [186cI-CTD (27)] from the plac  -CI OR2-62 promoter (28) on the lacOR2-62_186cI-CTD selection plasmid. 186cI-CTD sequesters
chromosomally encoded 186cI repressor (186cI
ts), from its binding site in the int
- 186 prophage. This activates aberrant lytic gene transcription from
the prophage, which results in signiﬁcantly inhibited growth or cell death, depending on the strength of the bait–prey interaction. Mutations in the
bait or prey fusion proteins that disrupt interaction reduce 186cI-CTD expression, allowing 186cI
ts to maintain repression of prophage lytic tran-
scription, permitting normal cell growth. (b) Strength of the indicated  CI-bait and RNAPa-prey fusion proteins interaction measured as b-gal
activity from the lacOR2-62_lacZ reporter gene in KS1. Data are mean±SD, n=3.(c) Selectivity for interaction: four plasmids encoding two pairs
of interacting bait and prey proteins [ CI_Arnt362 and RNAPa_AhR278,  CI_LGF2 and RNAPa_gal11p (35)] were co-transformed into KS1033
carrying the lacOR2-62_186cI-CTD selection plasmid, with induction of fusion protein expression. Plasmid incompatibility permits establishment of
only one of the two available  CI and RNAPa plasmids. Genotyping revealed the presence of non-interacting and interacting pairs in large and small
colonies, respectively. (d) and (e) Effect of 186cI-CTD production on colony size: induction of protein expression in KS1033 harbouring the lacOR2-
62_186cI-CTD selection and  CI_Arnt362 expression plasmids either with (d) or without (e) transformation of the RNAP_AhR278_lacZa mutagenic
library.
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reduced activity to almost background levels seen with
 CI alone (Figure 1b). To test the selectivity of the
RevB2H system, we cotransformed a mixture of four
plasmids encoding two pairs of interacting bait and prey
proteins,  CI_Arnt362 and RNAPa_AhR278,  CI_LGF2
and RNAPa_gal11p into KS1033 cells carrying the
lacOR2-62_186cI CTD selection plasmid. Genotyping of
different sized colonies showed that six out of six large
colonies harboured a mismatched interacting pair, while
ﬁve out of six small colonies carried the  CI_Arnt362 and
RNAPa_AhR278 interacting pair (Figure 1c), indicating
that the RevB2H system could readily discriminate
between interacting and non-interacting protein pairs.
No colonies tested harboured both the strongly interacting
 CI_LGF2 and RNAPa_gal11p expression plasmids, pre-
sumably due to the high 186cI CTD expression sequester-
ing all available 186cI
ts resulting in cell death, consistent
with the relative strength of the interactions measured as
b-gal activity (Figure 1b). Expression of both
 CI_Arnt362 and RNAPa_AhR278 in the presence of
the lacOR2-62_186cI CTD selection plasmid gave pre-
dominantly small colonies (Figure 1d), whereas when
RNAPa-AhR278 was absent, colony size had a normal
distribution (Figure 1e).
RevB2H identiﬁed amino acid substitutions in Arnt
PAS.A altering AhR/Arnt heterodimerization
A mutagenic library, over the region encoding Arnt
PAS.A, residues 152–362, was generated using error-prone
PCR (described in Supplementary Data) which we
estimated to contain an average of one amino acid
mutation per construct. This library was subcloned into
the  CI_Arnt362 expression vector, replacing the wt Arnt
PAS.A coding region. To improve the screening efﬁciency,
we incorporated lacZa complementation by fusing
the lacZa polypeptide (amino acids 1–39 of LacZ) to the
C-terminus of Arnt. As the host strain carries the
LacZ(M15) allele, which produces a mutant form of
b-gal lacking amino acids 11–41, expression of LacZa in
the  CI_Arnt362_LacZa fusion protein restores the func-
tionality of b-gal (36). This allows rapid discrimination of
nonsense and frame-shift mutations within the N-terminal
Arnt362 portion of the fusion protein, since by disrupting
the expression of the C-terminal LacZa peptide, these will
give rise to white colonies when plated on medium con-
taining X-gal. Cells carrying wt or missense mutations will
appear blue due to the restored catalytic activity of b-gal.
Alpha complementation also provides a screen for
unwanted mutations which directly or indirectly reduce
expression levels.
The Arnt PAS.A mutagenic library was transformed
into KS1033 harbouring the RNAPa_AhR278 expression
and lacOR2-62_186cI CTD selection plasmids and plated
on media containing IPTG and X-gal. Colonies that de-
veloped showed a marked size distribution, and large
colonies were either blue or white while small colonies
were predominantly blue. A total of approximately 8000
colonies were screened, and 192 large blue colonies
selected for further analysis. The  CI_Arnt362_lacZa
expression plasmids harbouring potential loss-of-
interaction mutations were isolated, and transformed
into E. coli KS1 (28). The forward two-hybrid provided
a rapid, quantitative method to validate the initial
screening result, allowing the strength of interaction
between AhR278 and putative Arnt PAS.A mutants to
be measured directly as a function of b-gal activity.
Isolates having <80% b-gal activity relative to wt Arnt
PAS.A were sequenced (Supplementary Table S1). In
this way, we identiﬁed 26 single amino acid mutations in
Arnt PAS.A that potentially reduced AhR278/Arnt362
heterodimerization. Two of these mutations, T208A and
H214R, appeared repeatedly, and mutation of C308 to
both tyrosine and arginine was found. As the RevB2H
system allows survival due to decreased levels of 186cI
CTD gene expression, false positives may emerge due to
spontaneous mutations elsewhere that reduce plasmid
copy number or reduce fusion protein expression in
some way. To eliminate such effects, the coding
sequence of each Arnt PAS.A mutation was cloned into
fresh  CI_Arnt362 expression vector, and re-analysed for
b-gal activity (Figure 2a). At this stage, we compared
activity to wt Arnt362 (i.e. Arnt bHLH.PAS.A), Arnt
bHLH alone without the adjacent PAS.A domain, and
Arnt362 having the G341D substitution, a mutation
within Arnt PAS.A identiﬁed in the Arnt deﬁcient
mouse hepatoma cell line, Hepa C4, which reduces dimer-
ization with AhR and HIF (37). These gave, respectively,
22 and 47% of wt activity in this assay. Twenty-two out of
the 26 Arnt PAS.A mutations isolated from the RevB2H
screening showed statistically signiﬁcant reduction in b-gal
production, consistent with having disrupted AhR278/
Arnt362 heterodimerization.
Although we had incorporated alpha complementation
in our RevB2H screen to eliminate severe  CI_Arnt362
expression and misfolding mutations, the observed
decrease in b-gal activity might in principle reﬂect
small reductions in levels of fusion protein or mutations
resulting in protein misfolding and degradation, rather
than the desired compromised AhR278/Arnt362
heterodimerization. To address this concern, the expres-
sion levels of all 22 positive  CI_Arnt362 PAS.A mutants
were assayed by quantitative ﬂuorescence-based western
blotting using afﬁnity puriﬁed  CI antibodies (Figure 2b
and c). While expression was quite variable with muta-
tions, protein levels relative to wt did not correlate with
reduced b-gal activity except for V306D, C308R and
A339D, suggesting that the lower activity seen for the re-
maining mutations was not likely to be predominantly the
result of protein instability. In fact, as many of the mutant
proteins showing reduced b-gal production expressed at
higher levels than wt Arnt, there may be greater effects
on dimerization than are reported by the assay.
The overall structure of the Arnt PAS.A putative
dimerization mutants was further characterized using
circular dichroism (CD) spectroscopy. Figure 2d and
Supplementary Figure S2 show the CD spectra of
nickel afﬁnity puriﬁed 6-Histidine tagged-Arnt362
(bHLH.PAS.A) wt and mutant proteins. Although there
were minor differences in the CD spectra of mutant
proteins, as well as differences in yield from the
Nucleic Acids Research,2011, Vol.39, No. 9 3699Figure 2. Single amino acid mutations in Arnt PAS.A domain with disrupted AhR/Arnt heterodimerization isolated using RevB2H. (a) The strength
of interaction between RNAPa_AhR278 and the potential  CI_Arnt362 loss-of-interaction mutants selected as large blue colonies from RevB2H was
measured in a standard forward bacterial two hybrid system with the lacZ reporter gene (28). Data are mean with 95% conﬁdence intervals, shown
as a percentage of b-gal activity obtained with wt  CI_Arnt362 protein, n=9. bHLH:  CI_Arnt bHLH domain only; *P<0.05 (one tailed unpaired
(continued)
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in b-gal activity using the LacZ reporter gene
(Figure 2a). Therefore we conclude that our data are con-
sistent with the mutations in Arnt PAS.A isolated using
the RevB2H system having disrupted dimerizaton with
AhR, rather than the reduced b-gal activity arising pri-
marily from gross misfolding or instability, and demon-
strate the utility of the additional alpha complementation
screening approach. Thus, from this analysis, we did not
discard any mutants as having reduced b-gal activity
arising simply from gross structural changes.
Arnt PAS.A mutation sites were clustered in key
structural elements and conserved throughout evolution
The mutations identiﬁed in Arnt PAS.A having deﬁcient
dimerization with AhR mapped across the entire PAS.A
region and clustered in predicted key structural elements
(Figure 2e). Only one mutation, L237R, was found in a
predicted insert loop region. Furthermore, most of the
mutations found in the N-terminal b-strands (bA and
bB) had relatively mild effects, whereas mutations within
the a-helical connector or C-terminal b-strands (bC, bD
and bE) tended to have more severe effects on AhR/Arnt
heterodimerization (cf Figure 2a). Interestingly,
amino acids D161 and E163 found N-terminal of the
structured PAS domain, in a sequence predicted to form
an a-helix (Figure 2e), also inﬂuenced dimerization, with
the E163K substitution having the largest single effect on
dimerization in the b-gal activity assay. Cross-species
alignment of Arnt PAS.A domains from ﬂy to ﬁsh and
mammals showed the mutation sites are highly conserved
throughout evolution, implying a signiﬁcant role of
these amino acid residues in function (Supplementary
Figure S3).
Arnt PAS.A mutations identiﬁed using the RevB2H
reduced AhR/Arnt transactivation activity and
dimerization in mammalian cells
As the RevB2H screen was performed in bacterial cells
with truncated proteins containing only the bHLH and
PAS.A domains, next we tested the effect of these muta-
tions in the context of full-length proteins in mammalian
cells in culture. In reporter gene assays using an artiﬁcial
XRE-driven luciferase reporter construct pML_6c_X (33),
most of the Arnt PAS.A mutants identiﬁed from the
RevB2H screen reduced transactivation by the AhR/
Arnt heterodimer, both without activating ligand and
upon treatment with the ligand YH439 (Figure 3a and
Supplementary Figure S4). In general, there was a clear
correlation between the effects on b-gal induction using
truncated proteins in bacteria and the function of
full-length proteins in mammalian cells. Signiﬁcantly,
mutants giving <60% of wt b-gal activity, i.e. E163K,
L221H, C265R, M267K, V306D, C308R and A339D,
were also severely compromised with full-length proteins
in mammalian cells, both without and in response to AhR
ligand (compare Figures 2a and 3a). These reductions in
reporter gene activity were unlikely due to poor expres-
sion, as levels of exogenous wt and mutants Arnt proteins
were mostly similar (Figure 3b). Expression of three
mutant proteins (i.e. D219V, A339D and S190P) was de-
tectably lower than wt Arnt. Arnt D219V mutant was
almost indistinguishable from wt in terms of reporter
gene activation, while A339D and S190P mutants were
>100-fold less active than wt protein in the absence of
ligand, which does not correlate with the small observed
reduction in protein expression.
In general, the difference in the reporter gene activation
between wt and mutant Arnt was greater in the absence of
ligand. Activation of the XRE-driven reporter gene in the
absence of ligand is commonly observed with exogenous
expression of AhR/Arnt (32,38) and most of the muta-
tions showed a reduction in this activity, consistent with
reduced dimerization through PAS.A. For the less severe
mutations, this was largely overcome in the presence of
ligand, presumably due to the addition of the PAS.B di-
merization interface (39).
Both the b-gal and luciferase reporter gene assays were
indirect measures of dimerization, with the reasonable as-
sumption that dimerization is required for reporter gene
activation. To demonstrate directly that the Arnt PAS.A
mutants identiﬁed using the RevB2H indeed have dis-
rupted AhR/Arnt heterodimerization, we stably expressed
a subset of Arnt mutants as full-length proteins with a
HisMyc tag in the Arnt-deﬁcient mouse hepatoma Hepa
C4 cell line (34), using lentiviral mediated infection.
HisMyc-tagged wt and mutant E163K, S190P, D217G
and M267K Arnt proteins from cell extracts treated with
YH439 in vitro were successfully captured by Ni resin to a
similar extent. However, there was a marked difference in
AhR co-immobilization, with only wt Arnt, but not the
mutant Arnt proteins, enabling signiﬁcant capture of AhR
(Figure 3d). AhR ligand YH439 promoted capture of
AhR/HisMyc_Arnt wt heterodimer from cell extracts to
the same extent as the prototypical AhR ligand,
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD; Figure 3c)
and similar results were obtained with TCDD (data not
shown). Thus, these mutations in Arnt PAS.A disrupted
AhR/Arnt heterodimerization in the full-length protein in
response to ligand.
Figure 2. Continued
Student’s t-test). (b) Expression of mutant  CI_Arnt362 relative to wt; mean±SEM. from three independent bacterial extracts. Percent symbol
denotes grouping by b-gal activity relative to wt from (a). (c) Shows a representative western blot. (d) CD spectra of wt H6_Arnt362 and selected
loss-of-interaction mutants, normalized to allow comparison with wt (30). CD spectra of all mutants are shown in Supplementary Figure S2. (e) The
dimerization deﬁcient mutations identiﬁed from RevB2H mapped onto the sequence of Arnt PAS.A, aligned with dPer PAS.A. dPer PAS.A is
representative of PAS.A domains, which have one to three insert loops within the PAS domain fold (25). The positions of secondary-structure
elements, including the predicted N-terminal a-helix are indicated above. The mutations are coloured according to the strength of disruption
observed in the b-gal assay; red: <60%, magenta: 61–70%, blue: 71–80% and green: >80% of wt activity, yellow: Hepa c4 mutation G341D (37).
Nucleic Acids Research,2011, Vol.39, No. 9 3701Arnt PAS.A mutations selectively alter dimerization with
partner proteins Sim1, Sim2s, NPAS4, HIF-1a and Arnt
itself
Since Arnt is the common dimerization partner for all
other proteins in the Arnt cluster (Supplementary Figure
S1), we looked at the effect of Arnt PAS.A mutants on
dimerization with bHLH.PAS proteins other than AhR.
Sim1/Arnt heterodimerization was assayed using a six
CNS midline enhancer (CME) driven luciferase reporter
gene construct derived from the Drosophila Sim target
gene toll 6 (33) (Supplementary Figure S4). Interestingly,
the E163K, V179A, S190P and D217G mutations, which
signiﬁcantly disrupted AhR/Arnt heterodimerization, had
little or no effect on Sim1/Arnt interaction in this assay
(Figure 4a). In contrast, mutations such as L221H,
C265R, V306A, C308R and A339D showed reduced
reporter gene expression for both Sim1/Arnt and AhR/
Arnt (c.f. Figure 3a). E163K, V179A, S190P and D217G
Arnt also had little effect on reporter gene activation when
partnered with Sim2s or NPAS4 (Figure 4b and c)
whereas M267K reduced activation for each of AhR,
Sim1, Sim2s and NPAS4.
Next, we used our Hepa C4 lines expressing wt or
mutant HisMyc-Arnt to investigate activation of proto-
typical endogenous target genes cytochrome P450 1A1
(CYP1A1) or vascular endothelial growth factor (VEGF)
by AhR/Arnt or HIF1-a/Arnt heterodimers, respectively.
The Arnt E163K, S190P and D217G mutations impaired
Figure 3. Arnt PAS.A mutations identiﬁed from RevB2H disrupt full-length AhR/Arnt heterodimerization in mammalian cells. (a) Activation of the
pML-6c-X XRE-driven reporter gene in 293T cells by HisMyc-tagged AhR and full-length wt or mutant HisMyc-tagged Arnt in response to vehicle
or the ligand YH439, shown as fold activation over basal levels (puro6) from endogenous protein. Data are mean±SD of transfections performed in
triplicate and representative of two independent experiments. (b) Expression of HisMyc_Arnt wt and mutants in the transfected cells used for the
reporter gene assay in (a), detected with anti-Arnt monoclonal antibody and Cy5 labelled anti-mouse secondary antibody. (c) Cytosolic extracts from
parental Arnt-deﬁcient mouse Hepa C4 cells (Arnt null) and the derived line constitutively expressing HisMyc-tagged wt Arnt, from an integrated
lentiviral vector, were treated in vitro with vehicle, TCDD or YH439. Protein captured by Ni resin was analysed by western blot, using anti-Myc
antibody for HisMyc_Arnt or anti-AhR antibody to detect co-immobilized AhR. (d) Mutations in Arnt reduced co-capture of AhR in Ni afﬁnity
pull-downs. Cytosolic extracts from the Arnt null and derived cell lines constitutively expressing wt or the indicated mutant HisMyc_Arnt from
integrated lentiviral vectors were in vitro transformed with YH439. Captured HisMyc_Arnt and AhR were detected by western blot using anti-Myc
and anti-AhR antibodies. i, 5% of input; B, fraction bound to Ni resin. Data are representative of three independent experiments.
3702 Nucleic Acids Research, 2011,Vol.39, No. 9Figure 4. Arnt mutations differentially alter dimerization with other partner proteins. Activation of the CME driven reporter (pML-6c-wt) in 293T
cells by wt or mutant HisMyc_Arnt together with hSim1_Myc (a), NPAS4_Myc (b) or hSim2s_Myc (c) shown as fold activation over basal levels
(puro6). Data are mean±SD of transfections performed in triplicate and are representative of two independent experiments. Hepa C4 cell lines
expressing wt, E163K, S190P or D217G HisMyc_Arnt were treated with vehicle, YH439 or 2,20-dipyridyl (DP) and assayed for CYP1A1 (d)o r
VEGF (e) mRNA induction by qRT-PCR. Data are mean±SEM, n=3. (f) Whole cell extracts from the Hepa C4 Arnt deﬁcient and derived cell
lines constitutively expressing wt, E163K, S190P or D217G HisMyc_Arnt were separated by SDS–PAGE, followed by western blotting for Myc
tagged Arnt and a-tubulin loading control. Dashed line indicates removal of an empty lane from the image. (g) Activation of the E-box driven
4(CACGTG)TKMPluc reporter gene in 293T cells by wt or mutant HisMyc_Arnt. Data are mean±SD of transfections performed in triplicate and
are representative of two independent experiments.
Nucleic Acids Research,2011, Vol.39, No. 9 3703AhR ligand-dependent CYP1A1 activation in a manner
consistent with activity measured in the XRE reporter
gene assays (Figure 4d). In contrast, the response of the
HIF1-a/Arnt target gene VEGF in the presence of the
hypoxia mimetic 2,20-dipyridyl showed that the E163K
and S190P Arnt mutant proteins were able to dimerize
with HIF-1a to induce VEGF expression to greater
levels relative to wt Arnt than with AhR on CYP1A1.
The D217G mutation signiﬁcantly reduced both AhR
and HIF-1a activity in this assay (Figure 4e). These dif-
ferences were not due to protein levels (Figure 4f). Our
data indicate that Arnt probably uses the same interface to
interact with each of its partner proteins, with particular
residues having partner-speciﬁc effects.
The effect of mutations in the Arnt PAS.A domain on
Arnt homodimerization was investigated by looking at the
ability of the full-length mutant proteins to activate tran-
scription in mammalian cells in culture using a reporter
gene driven by the canonical E-box sequence (6). Since
exogenous mutant Arnt protein levels were much greater
than endogenous wt Arnt (Figure 3b), competing
homodimer interactions with endogenous protein have
no signiﬁcant effect in this experiment. Overall, the
pattern was similar to that seen for heterodimerization
with partner proteins AhR or Sim1, suggesting the use
of the same interface for homo- and heterodimerization.
Surprisingly, the E163K mutation, which appeared
speciﬁc for the AhR/Arnt interaction, increased activity
of the Arnt homodimer by  2-fold relative to wt
(Figure 4g). This difference was even more dramatic
at sub-saturating concentration, where wt Arnt gave no
reporter gene induction while E163K Arnt showed
 2-fold induction, comparable to the maximum for
wt Arnt homodimer, suggesting the E163K mutation
resulted in stronger homodimer formation
(Supplementary Figure S5).
AhR mutant RevB2H screen
Having identiﬁed mutations in Arnt affecting dimer for-
mation, we applied the RevB2H screen to the AhR PAS.A
domain to isolate mutations in AhR which disrupted di-
merization with Arnt. The wt AhR PAS.A coding region
(amino acids 88–278) in the RNAPa_AhR278 expression
vector was replaced with a mutagenic library generated
using error-prone PCR and fused to the lacZa 1–39 poly-
peptide at the C-terminus to allow screening by alpha
complementation. The resulting AhR library was trans-
formed into KS1033 harbouring the  CI_Arnt362 expres-
sion and lacOR2-62_186cI CTD selection plasmids and
grown in selective conditions. As in the Arnt experiment,
the transformants arising showed a size distribution that
differed distinctly from those without library transform-
ation (Figure 1d and e). Again, large colonies which de-
veloped under selective conditions were either blue or
white and small colonies predominantly blue. Of approxi-
mately 4000 transformants, RNAPa_AhR278 expression
plasmids harbouring potential loss-of-interaction muta-
tions were isolated from 120 large blue colonies
and assayed for b-gal activity in the lacOR2-62_lacZ
reporter strain, E. coli KS1, with co-transformation of
 CI_Arnt362 expression plasmid. Putative AhR PAS.A
mutants having <90% of wt activity were sequenced
(Supplementary Table S1). At this stage, we found 14
single amino acid mutations in AhR PAS.A that poten-
tially reduced AhR278/Arnt362 heterodimerization. After
cloning the coding sequence of each AhR PAS.A mutation
into fresh RNAPa_AhR278 expression vector without the
LacZa fusion, mutants were re-analysed for b-gal activity.
From this we identiﬁed 10 AhR PAS.A mutations with a
statistically signiﬁcant reduction in b-gal activity, consist-
ent with having disrupted dimerization with Arnt
(Figure 5a). These were again spread across the PAS.A
region, clustered in the same structural elements as we
saw for the Arnt dimerization mutations (Figure 5d) and
largely conserved across species (Supplementary Figure
S6). There were also several residues in the region
N-terminal of the structured PAS domain that appeared
to inﬂuence dimerization with Arnt, as seen for Arnt.
On the XRE-driven luciferase reporter gene, the most
severe AhR PAS.A mutations, V124E, A131V, I160T,
L218P, G227C and F228L, reduced the ability of the
AhR/Arnt heterodimer to activate transcription
in full-length AhR in mammalian cells in culture, both
in the basal activation in the absence of stimulus and in
response to YH439 (Figure 5b). These observed differ-
ences were not due to protein expression levels
(Figure 5c). Interestingly, E158G and T264A, having
somewhat compromised dimerization with Arnt in the
LacZ bacterial reporter gene assay using truncated
bHLH.PAS.A proteins, showed reduced basal activity
but close to wt activation in response to exogenous
ligand, suggesting that addition of the PAS.B dimerization
interface in the ligand-bound form can compensate for
mild defects in PAS.A dimerization.
DISCUSSION
Protein–protein interaction is constant, dynamic and
governs every aspect of cellular processes. This is clearly
exempliﬁed in budding yeast Saccharomyces cerevisiae,
which is estimated to contain more than 30000 protein–
protein interactions for its approximately 6000 identiﬁed
genes (40,41). Thus, on average, every yeast protein inter-
acts with at least ﬁve others, demonstrating the essential
role of protein networking in biology. A mechanistic
understanding of protein interactions is important in
health and disease, since many diseases are interaction
related. Predictions suggest that at least 1200 of experi-
mentally veriﬁed disease-related mutations present in
Online Mendelian Inheritance in Man (OMIM) and
UniPort databases can be attributed to protein interaction
(42). A recent study of pair-wise TF interactions, for
more than 1000 TFs in human and mouse, demonstrates
how a better understanding of combinatorial TF inter-
actions will greatly advance our current understanding
and prediction accuracy on tissue differentiation and spe-
ciﬁcation (43).
A number of techniques have been developed to iden-
tify protein interactions, including TAP tag puriﬁcation
(44), and yeast, bacterial and mammalian two hybrid
3704 Nucleic Acids Research, 2011,Vol.39, No. 9approaches (28,45). More recently, studies of protein
interaction networks are providing a global picture of
the protein interactome landscape (41,43). Methods such
as yeast split-hybrid (46), one- plus two-hybrid (47), and
absence of interference (48), have been developed to de-
lineate interaction interfaces and deﬁne amino acids essen-
tial to interaction. These yeast based methods can be time
consuming and difﬁcult for plasmid retrieval. Here, we
describe a simple, robust bacterial system, RevB2H, to
our knowledge the ﬁrst reported bacterial system
designed to detect loss of protein interactions. We have
successfully incorporated alpha complementation, fusing
lacZa to the C-terminus of the mutagenic library, reducing
false positives and simplifying the subsequent validation
procedure. As a result, nonsense and frame-shift muta-
tions were readily ﬁltered out (Supplementary Table S1).
In addition, as the C-terminally encoded lacZa requires at
least some folding of the partner protein to function, this
approach helped to eliminate severe expression and
mis-folding mutants. In fact, we found that the CD
spectra of the Arnt mutant proteins were largely consistent
with there being no gross structural perturbation. Some
differences in the proportions of secondary structural
elements, which may be indicative of changes in the
local environment, were evident in the CD spectra for a
number of the mutants. It should be noted that the protein
concentration in the CD experiments varied with muta-
tions, since severe mutations generally resulted in lower
yield of puriﬁed protein. This can be attributed to
reduced Arnt homodimerization (Figure 4g) consistent
with previous work indicating that Arnt bHLH.PAS A
protein puriﬁes as a homodimer (13). Finally, the
RevB2H mutations were readily transferable to full-length
proteins, where effects on activity in mammalian cells
correlated well with that in the bacterial b-gal assays
using truncated proteins, encompassing only the
N-terminal bHLH-PAS.A region. This indicates that the
RevB2H system is robust and presents an easy alternative
to yeast systems for systematic study of mammalian
protein interactions.
Figure 5. Mutations in AhR PAS.A that alter dimerization with Arnt. (a) The strength of interaction between  CI_Arnt362 and the potential
RNAPa_AhR278 loss-of-interaction mutants selected as large blue colonies from RevB2H was measured in the forward bacterial two hybrid system
with the lacZ reporter gene (28). Data are mean with 95% conﬁdence intervals, shown as a percentage of b-gal activity obtained with wt
RNAPa_AhR278. bHLH: RNAPa_AhR bHLH domain only; *P<0.05 (one tailed unpaired Student’s t-test). (b) AhR PAS.A mutations identiﬁed
from RevB2H disrupted full-length AhR/Arnt function. Activation of the XRE-driven reporter gene in 293T cells by wt or mutant HisMyc_AhR and
HisMyc_Arnt in response to vehicle or the ligand YH439, shown as fold activation over basal levels (puro6) from endogenous protein. Data are
mean±SD of transfections performed in triplicate and representative of two independent experiments. (c) Expression of wt and mutant
HisMyc_AhR in the transfected cells used for the reporter gene assay in (b), detected by western blotting for Myc-tagged AhR and a-tubulin
loading control. (d) AhR mutations deﬁcient in dimerization with Arnt mapped onto the PAS.A sequence, illustrated with dPer PAS.A. See Figure 2e
legend for details. Colouring of mutations according to the strength of disruption observed in the b-gal assay (a): red: <60%, magenta: 61–80%,
green: >80% of wt activity.
Nucleic Acids Research,2011, Vol.39, No. 9 3705Based on known PAS domain structures and inter-
actions, the mechanism and speciﬁcity of dimerization
mediated by Arnt PAS.A could potentially involve either
the same or independent surfaces of the domain for homo-
and hetero- dimerization (9,17–21). Our data favours the
former, since most of the Arnt mutations we identiﬁed had
similar effects on both homo- and hetero-dimerization
with different partner proteins. Key residues discriminated
between partner proteins, showing partner-speciﬁc effects.
In particular, Arnt E163K, which had no effect on
Figure 6. Mutations altering dimerization of Arnt and AhR PAS.A domains deﬁne a putative dimerization interface. (a) Residues found to be
important for Arnt and AhR dimerization are illustrated on homology models of Arnt and AhR PAS.A domain. The mutations are coloured
according to the severity of the defect in the lacZ reporter assay. For Arnt red: <60%, magenta: 61–70%, blue: 71–80% and green: >80% of wt
activity (Figure 2a) and for AhR red: <60%, magenta: 61–80%, green: >80% of wt activity (Figure 5a). (b) Superimposition of PAS.A models of
Arnt and AhR onto the structure 3F1P of HIF-2a/Arnt PAS.B (49) suggests dimerization occurs through different interfaces for PAS A and PAS B
domains.
3706 Nucleic Acids Research, 2011,Vol.39, No. 9Sim1/Arnt, Sim2/Arnt, and NPAS4/Arnt dimerization,
and only a mild effect on HIF1a/Arnt dimerization, com-
pletely abolished AhR/Arnt interaction, and yet strength-
ened Arnt homodimerization. Arnt S190 was also selective
for the AhR/Arnt interaction, with the S190P mutation
having little effect on other Arnt partner proteins, while
substitution of D217 affected both AhR and HIF-1a but
not Sim1, Sim2s or NPAS4.
We generated homology models of the Arnt and AhR
PAS.A domains, using the dPER crystal structure (25) as
template, and mapped the residues that we found to be
important for dimerization onto these models (Figure 6a).
When the modelled structures were superimposed on the
crystal structure of the HIF-2a/Arnt PAS.B dimer, where
interaction is through the b-sheet surfaces (49), it was clear
that the most severe of our identiﬁed mutations in both
Arnt and AhR cluster on faces away from the HIF-2a/
Arnt PAS.B b-scaffold dimerization interface (Figure 6b).
This suggests the PAS.A interactions use a face of the
domain, encompassing a-C, b-C and b-D, that is different
from the HIF-2a/Arnt PAS.B interface, as well as other
examples of PAS domain interactions (9,17–21). Further,
AhR and Arnt appear to interact through equivalent
regions of PAS.A (Figure 6a). Partner speciﬁc Arnt
D217 is centrally located in the putative dimerization
interface in this model, while the S190P substitution on
the opposite face may alter interaction with AhR through
effects on packing. Arnt E163, where substitution with
lysine resulted in the most severe and discriminating alter-
ation to dimerization, lies outside the PAS fold, in a pre-
dicted a-helical extension. This may be functionally
equivalent to the N-terminal cap found in many PAS
domains, which forms an interaction interface in some
cases (20,21). While the packing of this predicted helix
in the Arnt structure is unknown, it could be positioned
to bring E163K close to the cluster of signiﬁcant residues
on Arnt (red and magenta in Figures 2 and 6) to form the
dimerization interface. Two residues in the predicted
N-terminal a-helix in AhR similarly appear important
for dimerization with Arnt, albeit with less drastic effects
than Arnt E163K, consistent with the suggestion that
these helices form part of the AhR/Arnt PAS.A dimeriza-
tion interface. A number of the less severe Arnt mutations
that reduced interaction with all partner proteins map on
the b-sheet surface in the model (lower view in Figure 6a),
thus may disrupt interaction indirectly as a result of rela-
tively minor perturbation of the b-scaffold. Alternatively,
the b-sheet surface may contribute in some manner to the
protein–protein interactions that regulate dimerization.
The mechanism of a common interface within which
particular residues control speciﬁcity occurs with other
dimeric TFs. The bHLH.ZIP TF Max can homodimerize
and heterodimerize with bHLH.ZIP proteins, Myc and
Mad. Structural studies show that in the Max/Max
homodimer, Q91 of one Max monomer interacts with
N92 of the other, stabilizing the dimer interface. The
presence of charged amino acid residues at corresponding
positions in Myc (R423 and R424) and Mad (E125)
further strengthens dimerization. As a result, Max prefer-
entially forms heterodimers with Myc and Mad over
homodimerization (23). Similarly, single amino acid
changes in mouse retinoid X receptor (RXR) alters
RXR dimer speciﬁcity, such that mRXR Y402A
displays signiﬁcantly weakened dimerization with
retinoid acid receptor (RAR), peroxisome proliferator
activating receptor (PPAR) and vitamin D receptor
(VDR), but a marked increase in homodimerization
(22). This mode of dimerization regulation may be
favoured during protein evolution, as computational
studies suggest that many dimeric TFs arise from gene
duplication, which initially results in homodimer forma-
tion. Subsequent diversiﬁcation of one of the genes then
accommodates more specialized function (50,51).
However, during this process, the mode of interaction is
likely to be preserved, with key residues deﬁning
speciﬁcity.
Arnt can form homodimers which bind to the canonical
E-box DNA sequence in vitro and in vivo (5–7). However,
the physiological signiﬁcance of Arnt homodimerization is
still unclear, partially due to the weak dimerization afﬁnity
between Arnt monomers. As a result, it is hard to inves-
tigate effects mediated by Arnt homodimers separately
from Arnt heterodimers. Here, we reported a mutant
form of Arnt which showed a marked increase in Arnt
homodimerization, at least in reporter gene assays,
which may be useful for studying the physiological role
of Arnt homodimers. In addition, sequence analysis show
that E163 is also conserved between Arnt and BMAL 1
and 2. Thus, it will be interesting to investigate the effect
of the same mutation on BMAL, since like Arnt, BMAL
can homodimerize and heterodimerize with proteins such
as Clock (Supplementary Figure S1), both of which are
essential proteins in regulation of circadian rhythm.
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